A case of SIFD syndrome caused by novel compound heterozygous variants of TRNT1 gene.
10.3760/cma.j.cn511374-20200716-00517
- Author:
Juanjuan WANG
1
;
Xiaoliang HE
;
Denghuan CHEN
;
Shouwei HANG
;
Yutong GAO
;
Xu LI
;
Kefei HU
;
Chuanqing BAI
;
Yuqing CHEN
Author Information
1. Department of Endocrinology, Rheumatism and Immunology, Anhui Provincial Children's Hospital, Hefei, Anhui 230051, China. 894839405@qq.com.
- Publication Type:Journal Article
- MeSH:
Genetic Testing;
Humans;
Nucleotidyltransferases
- From:
Chinese Journal of Medical Genetics
2021;38(10):977-980
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To detect variant of TRNT1 gene in a child featuring sideroblastic anemia with B-cell immunodeficiency, periodic fever and developmental delay (SIFD).
METHODS:The proband and his parents were analyzed through trio-whole exome sequencing. Sanger sequencing and bioinformatic analysis were carried out to verify the candidate variant sites associated with the clinical phenotype.
RESULTS:Genetic testing showed that the proband has carried compound heterozygous variants of the TRNT1 gene, namely c.88A>G(p.Met30Val) and c.363G>T(p.Glu121Asp). Sanger sequencing confirmed that the variants were respectively inherited from his father and mother. The variants were unreported previously. By bioinformatic analysis, both variants were predicted to affect the stability of binding of the TRNT1 protein with tRNA. Based on the American College of Medical Genetics and Genomics standards and guidelines, c.88A>G and c.363G>T variants of TRNT1 gene were predicted to be uncertain significance (PM2+PP3+PP4) and likely pathogenic (PM1+PM2+PP3+PP4), respectively.
CONCLUSION:The c.88A>G (p.Met30Val) and c.363G>T(p.Glu121Asp) compound heterozygous variants of the TRNT1 gene probably underlay the disease in this patient. Above finding has enriched the spectrum of TRNT1 gene variants.
